Variant report
Variant | esv3323947 |
---|---|
Chromosome Location | chr6:167235962-167240360 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:2)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:167234510..167236019-chr6:167237889..167239702,2 | MCF-7 | breast: | |
2 | chr6:166870182..166872414-chr6:167234943..167236564,2 | K562 | blood: | |
3 | chr6:167234510..167236019-chr6:167237889..167239702,2 | MCF-7 | breast: | |
4 | chr6:167232177..167234702-chr6:167235338..167237852,2 | K562 | blood: |
(count:2 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-FGFR1OP-11 | chr6:167237778-167238313 | NONHSAT116055 |
2 | lnc-FGFR1OP-11 | chr6:167237176-167237266 | NONHSAT116055 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs190651486 | chr6:167235993-167235994 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs536510543 | chr6:167236074-167236075 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs16899555 | chr6:167236088-167236089 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs538853076 | chr6:167236139-167236140 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs184150012 | chr6:167236146-167236147 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs566200841 | chr6:167236223-167236224 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs140027419 | chr6:167236243-167236244 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs1099662 | chr6:167236250-167236251 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs140391861 | chr6:167236258-167236259 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs576143005 | chr6:167236269-167236270 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs535776452 | chr6:167236277-167236278 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs201414034 | chr6:167236278-167236279 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs71979866 | chr6:167236285-167236286 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs76159407 | chr6:167236291-167236292 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs149831301 | chr6:167236295-167236296 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs187875693 | chr6:167236395-167236396 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs114007726 | chr6:167236401-167236402 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs192441231 | chr6:167236500-167236501 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs371792586 | chr6:167236518-167236519 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs573001517 | chr6:167236532-167236533 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs150713433 | chr6:167236560-167236561 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs184487933 | chr6:167236563-167236564 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs533211695 | chr6:167236567-167236568 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs560902534 | chr6:167236597-167236598 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs531310590 | chr6:167236621-167236622 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs1099663 | chr6:167236632-167236633 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
27 | rs564820064 | chr6:167236656-167236657 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs555458693 | chr6:167236728-167236729 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs569687071 | chr6:167236752-167236753 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs547627190 | chr6:167236774-167236775 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs531122765 | chr6:167236788-167236789 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs530293835 | chr6:167236790-167236791 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs12211670 | chr6:167236919-167236920 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs374107770 | chr6:167236923-167236924 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs3220459 | chr6:167236924-167236925 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs58335817 | chr6:167236926-167236927 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs57340073 | chr6:167236927-167236928 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs57809208 | chr6:167236949-167236950 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs66707164 | chr6:167236955-167236956 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs56187218 | chr6:167236957-167236958 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs199784318 | chr6:167236962-167236963 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs569764280 | chr6:167236971-167236972 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs537040471 | chr6:167237062-167237063 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs558638947 | chr6:167237152-167237153 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs570812943 | chr6:167237218-167237219 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
46 | rs538849471 | chr6:167237238-167237239 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
47 | rs55897486 | chr6:167237246-167237247 | Weak transcription | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs1099664 | chr6:167237294-167237295 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs187347309 | chr6:167237311-167237312 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs1099665 | chr6:167237343-167237344 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Ependymoma | 16718352 | CNVD |
Gastric cancer | 17908304 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 16272173 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Breast cancer | 21858162 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Developmental delay | 19490664 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Leukemia | 18688285 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Prostate cancer | 18632612 | CNVD |
Lung cancer | 18438408 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Esophageal cancer | 21851588 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Breast cancer | 17133270 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Developmental delay | 21147756 | CNVD |
Chordoma | 18071362 | CNVD |
Glioblastoma multiforme | 19435819 | CNVD |
Ovarian cancer | 21720365 | CNVD |
abnormal development | 18461090 | CNVD |
Epilepsy | 22083797 | CNVD |
Myelofibrosis | 22110671 | CNVD |
chordoma | 19801981 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Autism | 17483303 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Acute myeloid leukemia | 19651601 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Autism | 22549408 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:167221800-167244400 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
2 | chr6:167235400-167236400 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
3 | chr6:167235600-167239000 | Weak transcription | Brain Anterior Caudate | brain |
4 | chr6:167238000-167238400 | ZNF genes & repeats | ES-UCSF4 Cell Line | embryonic stem cell |
5 | chr6:167238000-167238400 | ZNF genes & repeats | Breast Myoepithelial Primary Cells | Breast |
6 | chr6:167238200-167238400 | Bivalent/Poised TSS | Fetal Brain Male | brain |
7 | chr6:167238400-167244400 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
8 | chr6:167238600-167240000 | Enhancers | Brain Dorsolateral Prefrontal Cortex | brain |
9 | chr6:167239000-167239400 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
10 | chr6:167239000-167239400 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
11 | chr6:167239000-167239400 | Enhancers | Ovary | ovary |
12 | chr6:167239000-167239800 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
13 | chr6:167239000-167241800 | Enhancers | Brain Anterior Caudate | brain |
14 | chr6:167239200-167239400 | Enhancers | Brain Cingulate Gyrus | brain |
15 | chr6:167239200-167240000 | Enhancers | Left Ventricle | heart |
16 | chr6:167239200-167240000 | Enhancers | NH-A | brain |
17 | chr6:167239400-167240000 | Enhancers | HSMMtube | muscle |
18 | chr6:167240000-167240200 | Enhancers | Brain Cingulate Gyrus | brain |